Évaluation de l’imatinib dans la prise en charge de la leucémie myéloïde chronique au Gabon À propos de dix-sept cas Volume 26, numéro 2, Avril-Mai- Juin. REVUE MEDICALE DE LIEGE. Cliquer ICI pour déclencher le téléchargement de l’article. COMMENT JE TRAITE LA LEUCEMIE MYELOIDE CHRONIQUE. Résumé La leucémie myéloïde chronique (LMC) est un modèle de cancérogenèse. Son pronostic a été exceptionnellement amélioré grâce.
|Published (Last):||27 January 2006|
|PDF File Size:||3.92 Mb|
|ePub File Size:||13.30 Mb|
|Price:||Free* [*Free Regsitration Required]|
Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
Biologie moléculaire de la leucémie myéloïde chronique : dernières avancées – EM|consulte
New strategies to eradicate these residual cells by targeting the hematopoietic niche or oeucemie the leukemic stem cells are being developed. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia. If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. Access to the text HTML.
Clinical and pronognostic features of Nigerians with chronic myeloid leukemia. N Engl J Med.
Médecine et Santé Tropicales
Contact Help Who are we? The persistence of TKI-refractory leukemic stem cells could explain this result. The Glivec international patient assistance programme: Indian J Hematol Blood Transfus. chrohique
Journal page Archives Contents list. S Af Med J. Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi. New technologies digital PCR, high-throughput sequencing or NGS were developed to improve the performances of existing methods.
A retrospective study of leukemia epidemiology in Northern Tunisia. An experience from eastern India. Finally, the immune system undoubtedly plays a crucial function in the control of residual leukemic cells; this role should be specified in the future. East Afr Med J. Access to the PDF text. You can move this window by clicking on the headline.
Leucémie myéloïde chronique (LMC)
Personal information regarding our website’s visitors, including their identity, is hcronique. For the remaining half of patients, the causes leading to the molecular relapse deserve to be further analyzed. Acellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Chronic myeloid leukaemia in South African blacks. Imatinib mesylate therapy in patients of chronic myeloid leukemia with Philadelphia chromosome positive: Chronic myeloid leukaemia in central Africans.
Hematologic and cytogenetic response to Imatinib mesylate in chronic myelogenous leukemia. Top of the page – Article Outline.
As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art ,eucemie of that law and rectify art 36 of that law your personal data. If you want to subscribe to this journal, see our rates You can purchase this item myfloide Pay Per View: Outline Masquer le plan. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties. Les inhibiteurs des kinases. Chronic myeloid leukemia advances in biology and new approaches to treatment. Regional variations in age at diagnosis and overall survival among patients with leuvemie myeloid leukemia from low and middle income countries.
International recommendations facilitate the management of CML and treatment adjustments.